E Magnus Ohman Selected Research

Antihypertensive Agents (Antihypertensives)

8/2013	Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis.
4/2013	Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

E Magnus Ohman Research Topics

Disease

121	Acute Coronary Syndrome 01/2022 - 01/2002
92	Hemorrhage 01/2023 - 05/2004
89	Myocardial Infarction 12/2023 - 02/2002
45	ST Elevation Myocardial Infarction 02/2024 - 08/2002
41	Stroke (Strokes) 12/2023 - 05/2004
30	Unstable Angina 10/2021 - 08/2002
28	Heart Failure 12/2023 - 01/2002
26	Thrombosis (Thrombus) 01/2023 - 01/2001
20	Cardiogenic Shock 12/2022 - 08/2003
19	Ischemia 01/2023 - 06/2002
19	Infarction (Infarctions) 01/2022 - 02/2002
16	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 01/2002
16	Non-ST Elevated Myocardial Infarction 05/2017 - 08/2003
13	Diabetes Mellitus 01/2023 - 06/2002
12	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 01/2001
12	Thrombocytopenia (Thrombopenia) 12/2012 - 02/2005
9	Hypertension (High Blood Pressure) 12/2017 - 01/2002
8	Chronic Renal Insufficiency 09/2022 - 03/2006
7	Myocardial Ischemia (Ischemic Heart Diseases) 03/2015 - 01/2002
7	Chest Pain (Chest Pains) 04/2008 - 01/2001
6	Pathologic Constriction (Stenosis) 01/2023 - 06/2014
6	Atrial Fibrillation 01/2019 - 09/2003
6	Vascular Diseases (Vascular Disease) 01/2019 - 10/2009
5	Hypercholesterolemia 10/2023 - 04/2006
5	Renal Insufficiency (Renal Failure) 12/2017 - 09/2006
5	Necrosis 03/2008 - 01/2001
4	Peripheral Arterial Disease 10/2023 - 08/2013
4	Atherosclerosis 08/2013 - 03/2008
3	Shock 01/2019 - 09/2011
3	Heart Diseases (Heart Disease) 11/2015 - 01/2001
3	Ischemic Stroke 01/2014 - 09/2004
3	Body Weight (Weight, Body) 08/2013 - 06/2009
2	Obesity 10/2023 - 09/2008
2	Acute Kidney Injury (Acute Renal Failure) 12/2022 - 06/2015
2	Overweight 10/2022 - 06/2009
2	Neoplasms (Cancer) 01/2016 - 01/2016
2	Transient Ischemic Attack 06/2015 - 12/2006
2	Death (Near-Death Experience) 01/2015 - 12/2009

Drug/Important Bio-Agent (IBA)

38	Heparin (Liquaemin)FDA LinkGeneric 12/2014 - 09/2004
36	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2023 - 06/2002
34	Clopidogrel (Plavix)FDA Link 01/2020 - 04/2006
30	Glycoproteins (Glycoprotein)IBA 03/2015 - 05/2004
24	bivalirudin (Angiomax)FDA Link 12/2014 - 09/2004
23	Prasugrel Hydrochloride FDA Link 01/2020 - 07/2010
20	TicagrelorIBA 10/2023 - 12/2016
17	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2001
17	TroponinIBA 04/2017 - 01/2001
13	Platelet Membrane Glycoprotein IIbIBA 12/2010 - 12/2002
11	AntithrombinsIBA 12/2012 - 02/2005
10	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2023 - 01/2016
10	Eptifibatide (Integrilin)FDA Link 07/2010 - 02/2002
10	Enoxaparin (Lovenox)FDA LinkGeneric 03/2010 - 06/2004
9	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2021 - 01/2006
8	Fibrinolytic Agents (Antithrombotic Agents)IBA 08/2017 - 05/2004
7	CreatinineIBA 04/2017 - 06/2002
7	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 08/2013 - 03/2004
7	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 06/2010 - 05/2004
6	omega-Chloroacetophenone (Mace)IBA 12/2023 - 10/2015
6	AnticoagulantsIBA 01/2022 - 09/2007
5	Troponin T (Troponin T1)IBA 01/2017 - 06/2002
5	MB Form Creatine KinaseIBA 04/2007 - 04/2003
5	Platelet Membrane GlycoproteinsIBA 02/2007 - 08/2002
5	Creatine Kinase (Creatine Phosphokinase)IBA 01/2006 - 01/2001
4	apixabanIBA 01/2022 - 01/2016
4	RivaroxabanIBA 01/2019 - 05/2017
4	Abciximab (ReoPro)FDA Link 07/2010 - 09/2002
4	ORALIT (ORS)IBA 05/2009 - 09/2006
4	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2007 - 02/2002
3	Thrombin Receptors (Thrombin Receptor)IBA 01/2022 - 01/2016
3	Warfarin (Coumadin)FDA LinkGeneric 01/2019 - 02/2008
3	Glucose (Dextrose)FDA LinkGeneric 05/2017 - 01/2006
3	Hemoglobins (Hemoglobin)IBA 04/2017 - 02/2009
3	Proliferating Cell Nuclear Antigen (PCNA)IBA 03/2015 - 11/2014
3	Troponin IIBA 11/2007 - 04/2003
3	Tenecteplase FDA Link 07/2005 - 09/2004
3	Tirofiban (Aggrastat)FDA Link 07/2005 - 09/2002
3	paragonIBA 04/2003 - 08/2002
2	Mineralocorticoid Receptor AntagonistsIBA 10/2020 - 02/2014
2	Purinergic P2Y Receptor AntagonistsIBA 08/2020 - 12/2016
2	pro-brain natriuretic peptide (1-76)IBA 10/2019 - 07/2017
2	MicroRNAs (MicroRNA)IBA 10/2019 - 01/2017
2	Cytochrome P-450 CYP2C19IBA 01/2019 - 03/2016
2	C-Reactive ProteinIBA 07/2017 - 02/2011
2	Ranolazine FDA Link 05/2017 - 01/2016

Therapy/Procedure

101	Therapeutics 01/2023 - 07/2002
91	Percutaneous Coronary Intervention 02/2024 - 09/2002
30	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 10/2023 - 05/2004
14	Stents 01/2020 - 08/2003
10	Thrombolytic Therapy 09/2008 - 02/2002
9	Drug-Eluting Stents 03/2022 - 06/2003
9	Counterpulsation (External Counterpulsation) 01/2019 - 06/2003
7	Secondary Prevention 08/2017 - 08/2003
5	Catheters 01/2022 - 06/2002
5	Blood Transfusion (Blood Transfusions) 06/2015 - 10/2005
5	Contraindications 05/2010 - 05/2007
4	Length of Stay 12/2022 - 12/2005
4	Heart-Assist Devices 01/2022 - 01/2015
4	Patient Readmission 01/2015 - 10/2009
4	Erythrocyte Transfusion 05/2009 - 03/2005
3	Drug Therapy (Chemotherapy) 02/2014 - 02/2009